IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL

Sartor, A. O.; Bodrogi, I.; Gravis, G.; Shen, L.; Ozguroglu, M.; Oudard, S.; de Bono, J. S.; Hansen, S.; Machiels, J.; Kocak, I.

dc.contributor.author	Sartor, A. O.
dc.contributor.author	Bodrogi, I.
dc.contributor.author	Gravis, G.
dc.contributor.author	Shen, L.
dc.contributor.author	Ozguroglu, M.
dc.contributor.author	Oudard, S.
dc.contributor.author	de Bono, J. S.
dc.contributor.author	Hansen, S.
dc.contributor.author	Machiels, J.
dc.contributor.author	Kocak, I.
dc.date.accessioned	2021-03-05T07:11:00Z
dc.date.available	2021-03-05T07:11:00Z
dc.identifier.citation	Oudard S., de Bono J. S. , Ozguroglu M., Hansen S., Machiels J., Kocak I., Gravis G., Bodrogi I., Shen L., Sartor A. O. , "IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL", 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.307-308
dc.identifier.other	vv_1032021
dc.identifier.other	av_92767a08-6ad5-4f81-b432-3e42b3b566ab
dc.identifier.uri	http://hdl.handle.net/20.500.12627/98778
dc.language.iso	eng
dc.subject	Klinik Tıp
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp (MED)
dc.title	IMPACT OF CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) ON OVERALL SURVIVAL (OS) AT 2 YRS AND IN PATIENTS (PTS) WITH AGGRESSIVE DISEASE: POST-HOC ANALYSES OF TROPIC TRIAL
dc.type	Bildiri
dc.contributor.department	Assistance Publique Hopitaux Paris (APHP) , ,
dc.identifier.volume	23
dc.contributor.firstauthorID	140160

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Bildiri [64839]

Show simple item record